Oral Cavity Carcinoma — Trials

Oral Cavity Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

310 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 94
Recruiting: 43
Ph III recruiting: 9
Growth YoY: +13.6%
Industry share: 6%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (38)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06016400	Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma	unknown	Phase 2 / Phase 3	412	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER	1	Aug 29, 2023	clinicaltrials

Data updated 23 days agoSource updated Aug 29, 2023source: clinicaltrials